Literature DB >> 7099713

Cryopreservation of Babesia bovis for in vitro cultivation.

D A Palmer, G M Buening, C A Carson.   

Abstract

The most efficient procedure for cryopreserving viable Babesia bovis organisms for in vitro cultivation consists of freezing extracellular parasites in a solution of 10% (w/v) polyvinylpyrrolidone (PVP) using a cooling rate of 20 degrees C/min. Although cultures can be established from thawed infected erythrocytes, the plating efficiency is relatively low. Freezing extracellular parasites resulted in plating efficiency up to 25%, when thawed and placed in culture. Glycerin or dimethyl sulphoxide (Me2SO) can be used successfully in the cryopreservation of B. bovis but apparent toxic effects greatly decrease their efficiency. B. bovis parasites have been kept to -196 degrees C for 60 days with no appreciable reduction in plating efficiency.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7099713     DOI: 10.1017/s0031182000052835

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  18 in total

1.  Characterization of allelic variation in the Babesia bovis merozoite surface antigen 1 (MSA-1) locus and identification of a cross-reactive inhibition-sensitive MSA-1 epitope.

Authors:  C E Suarez; M Florin-Christensen; S A Hines; G H Palmer; W C Brown; T F McElwain
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Reduced parasitemia observed with erythrocytes containing inositol hexaphosphate.

Authors:  C L Mintzer; P Deloron; A Rice-Ficht; D Durica; D K Struck; C A Roessner; C Nicolau; G M Ihler
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

3.  Interstrain conservation of babesial RAP-1 surface-exposed B-cell epitopes despite rap-1 genomic polymorphism.

Authors:  C E Suarez; T F McElwain; I Echaide; S Torioni de Echaide; G H Palmer
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Comparison of cryoprotectants in the preservation of Theileria parva sporozoites using an in vitro infectivity assay.

Authors:  E N Kimbita; R S Silayo; T T Dolan
Journal:  Trop Anim Health Prod       Date:  2001-02       Impact factor: 1.559

5.  In vivo binding of immunoglobulin M to the surfaces of Babesia bigemina-infected erythrocytes.

Authors:  I E Echaide; S A Hines; T F McElwain; C E Suarez; T C McGuire; G H Palmer
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  In vitro inhibition of multiplication of Babesia bigemina by using monoclonal antibodies.

Authors:  J V Figueroa; G M Buening
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

7.  Immunogenic B-cell epitopes of Babesia bovis rhoptry-associated protein 1 are distinct from sequences conserved between species.

Authors:  C E Suarez; G H Palmer; S A Hines; T F McElwain
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Monoclonal antibody to a conserved epitope on proteins encoded by Babesia bigemina and present on the surface of intact infected erythrocytes.

Authors:  S Shompole; L E Perryman; F R Rurangirwa; T F McElwain; D P Jasmer; A J Musoke; C W Wells; T C McGuire
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Detection of Babesia bigemina-infected carriers by polymerase chain reaction amplification.

Authors:  J V Figueroa; L P Chieves; G S Johnson; G M Buening
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

Review 10.  Cultivation of Babesia and Babesia-like blood parasites: agents of an emerging zoonotic disease.

Authors:  Frederick L Schuster
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.